This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: University of Innsbruck. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: The Innovative Contributions of Stefan Schwaiger
Introduction
Stefan Schwaiger is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperplastic diseases. With a total of 2 patents, his work focuses on the development of innovative medical compositions.
Latest Patents
Stefan Schwaiger's latest patents include pharmaceutical compositions comprising lignans and their derivatives for treating hyperplastic diseases. These compositions are derived from specific compounds obtained from the Edelweiss plant. A preferred compound identified in his patents is leoligin, which has shown potential in treating various hyperplastic conditions such as intimal hyperplasia, stenosis, restenosis, and atherosclerosis. Additionally, these compounds may be utilized in the treatment of proliferative diseases, including leukemia, prostate cancer, and lung cancer. The inventions also encompass medical devices that incorporate these compounds, enhancing their therapeutic applications.
Career Highlights
Throughout his career, Stefan Schwaiger has been associated with prestigious institutions such as the University of Innsbruck and the University of Münster. His work has contributed to advancing medical research and developing effective treatments for serious health conditions.
Collaborations
Stefan has collaborated with esteemed colleagues, including Hermann Stuppner and David Bernhard, further enriching his research endeavors and expanding the impact of his inventions.
Conclusion
Stefan Schwaiger's innovative work in pharmaceutical compositions highlights his commitment to addressing critical health challenges. His contributions continue to pave the way for advancements in medical treatments and therapies.